Market Overview:
The global non-invasive drug delivery device market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for needle-free drug delivery devices, and technological advancements in the field of non-invasive drug delivery devices. Based on type, the global non-invasive drug delivery device market is segmented into liquid-based needle-free injector and powder-based needle free injector. The liquid based needle free injector segment is expected to account for a larger share of the global market than the powder based needle free injector segment during the forecast period from 2018 to 2030. This can be attributed to factors such as ease of use and accuracy offered by liquid based needles free injectors over powder based needles free injectors.
Product Definition:
A non-invasive drug delivery device is a medical device that is used to deliver drugs to the body without using needles. These devices typically use small tubes called catheters to deliver the drugs directly to the desired location in the body. This type of drug delivery can be less painful and more comfortable for patients than traditional needle injections. Additionally, it can help minimize potential damage to tissue and reduce the risk of infection.
Liquid-Based Needle-Free Injector:
Liquid-based needle-free injector is a new technology that uses a combination of water and biocompatible liquid to deliver the drug. The device works by creating and maintaining an emulsion between the drug and the liquid, which reduces friction & increases accuracy when it comes to injecting drugs.
The Needle Free Injectors (NFIs) market has been witnessing significant growth over recent years due to increasing demand for painless injection devices with higher efficacy & potency.
Powder-Based Needle-Free Injector:
Powder-based needle-free injector is a new technology that uses solid particles such as microparticles, nanoparticles or liquid to deliver the drug. Needle-free injectors have been rapidly growing in popularity and are being widely accepted by healthcare professionals across the globe. The major advantage of using this device is that there is no need for a sharp pointy needles like with other traditional methods of injecting drugs into the bloodstream which reduces pain and increases safety for patients.
Application Insights:
The diabetes management segment dominated the global non-invasive drug delivery device market in 2017. The growing prevalence of diabetes and the rising need to control its symptoms are some of the key factors contributing to this growth. According to WHO, approximately 463 million people were affected by diabetes worldwide in 2018, with an estimated 9% of population being diagnosed with the disease that same year.
Non-invasive injections have been proven effective for treating type 2 diabetes as well as insulin dependent Diabetes Mellitus (IDDM). Devices such as insulin pumps and continuous glucose monitors are used by patients suffering from IDDM or type 1 for delivering insulin therapy; however, these devices do not deliver painkillers or other drugs needed for managing pain and other diseases effectively. Thus, a significant number of companies are focusing on developing advanced products that will allow diabetic patients administer their daily medication through a mouthpiece without having to manually inject it every day.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of pharmaceutical companies, which are continuously developing advanced liquid-based and powder-based non-invasive drug delivery devices for therapeutic and medical applications. Moreover, increasing government initiatives to promote NIDD technology is also expected to drive regional growth over the forecast period. For instance, in March 2016, needle stick injury prevention program by CDC was introduced as part of its Safer Sex & Injury Prevention Program launched in 2003 by then US President George W Bush ‘Healthy People’ initiative aimed at preventing injuries caused during sex.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as growing healthcare expenditure levels coupled with rising awareness about various advanced technologies among end users including patients and physicians especially from China & India region will boost demand for these devices during the forecast years.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the increasing number of geriatric patients, who are more susceptible to surgical complications and are increasingly being preferred for surgery over traditional open procedures.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is on the rise globally, which is driving the demand for better and more effective treatment options such as non-invasive drug delivery devices.
- Technological advancements in drug delivery devices: Drug delivery device manufacturers are constantly innovating their products in order to make them easier to use and more efficient in terms of delivering drugs directly into the target tissues or organs. This is resulting in increased adoption rates of these devices by physicians worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-Invasive Drug Delivery Device Market Research Report
By Type
Liquid-Based Needle-Free Injector, Powder-Based Needle-Free Injector
By Application
Diabetes Management, Vaccine Management, Pain Management, Respiratory Management, Others
By Companies
Novartis AG, Inovio Pharmaceuticals, Inc., Medtronic Plc., Tandem Diabetes Care, Inc., Teva Pharmaceutical Industries Ltd., Crossject Medical Technology, Adherium Ltd., Sensirion AG, Diabeloop, PharmaJet, PenJet, Portal Instruments, Capsule Technologies, Propeller Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
Global Non-Invasive Drug Delivery Device Market Report Segments:
The global Non-Invasive Drug Delivery Device market is segmented on the basis of:
Types
Liquid-Based Needle-Free Injector, Powder-Based Needle-Free Injector
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes Management, Vaccine Management, Pain Management, Respiratory Management, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis AG
- Inovio Pharmaceuticals, Inc.
- Medtronic Plc.
- Tandem Diabetes Care, Inc.
- Teva Pharmaceutical Industries Ltd.
- Crossject Medical Technology
- Adherium Ltd.
- Sensirion AG
- Diabeloop
- PharmaJet
- PenJet
- Portal Instruments
- Capsule Technologies
- Propeller Health
Highlights of The Non-Invasive Drug Delivery Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid-Based Needle-Free Injector
- Powder-Based Needle-Free Injector
- By Application:
- Diabetes Management
- Vaccine Management
- Pain Management
- Respiratory Management
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-Invasive Drug Delivery Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A non-invasive drug delivery device is a medical device that helps to deliver medications directly to the target area. Non-invasive devices can be inserted through the skin, mouth, or nose, and may use ultrasound or heat to help ensure accurate placement.
Some of the key players operating in the non-invasive drug delivery device market are Novartis AG, Inovio Pharmaceuticals, Inc., Medtronic Plc., Tandem Diabetes Care, Inc., Teva Pharmaceutical Industries Ltd., Crossject Medical Technology, Adherium Ltd., Sensirion AG, Diabeloop, PharmaJet, PenJet, Portal Instruments, Capsule Technologies, Propeller Health.
The non-invasive drug delivery device market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Non-Invasive Drug Delivery Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Non-Invasive Drug Delivery Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Non-Invasive Drug Delivery Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Non-Invasive Drug Delivery Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Non-Invasive Drug Delivery Device Market Size & Forecast, 2020-2028
4.5.1 Non-Invasive Drug Delivery Device Market Size and Y-o-Y Growth
4.5.2 Non-Invasive Drug Delivery Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Liquid-Based Needle-Free Injector
5.2.2 Powder-Based Needle-Free Injector
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diabetes Management
6.2.2 Vaccine Management
6.2.3 Pain Management
6.2.4 Respiratory Management
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Non-Invasive Drug Delivery Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Non-Invasive Drug Delivery Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Liquid-Based Needle-Free Injector
9.6.2 Powder-Based Needle-Free Injector
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diabetes Management
9.10.2 Vaccine Management
9.10.3 Pain Management
9.10.4 Respiratory Management
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Liquid-Based Needle-Free Injector
10.6.2 Powder-Based Needle-Free Injector
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diabetes Management
10.10.2 Vaccine Management
10.10.3 Pain Management
10.10.4 Respiratory Management
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Liquid-Based Needle-Free Injector
11.6.2 Powder-Based Needle-Free Injector
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diabetes Management
11.10.2 Vaccine Management
11.10.3 Pain Management
11.10.4 Respiratory Management
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Liquid-Based Needle-Free Injector
12.6.2 Powder-Based Needle-Free Injector
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diabetes Management
12.10.2 Vaccine Management
12.10.3 Pain Management
12.10.4 Respiratory Management
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Liquid-Based Needle-Free Injector
13.6.2 Powder-Based Needle-Free Injector
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diabetes Management
13.10.2 Vaccine Management
13.10.3 Pain Management
13.10.4 Respiratory Management
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Non-Invasive Drug Delivery Device Market: Competitive Dashboard
14.2 Global Non-Invasive Drug Delivery Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis AG
14.3.2 Inovio Pharmaceuticals, Inc.
14.3.3 Medtronic Plc.
14.3.4 Tandem Diabetes Care, Inc.
14.3.5 Teva Pharmaceutical Industries Ltd.
14.3.6 Crossject Medical Technology
14.3.7 Adherium Ltd.
14.3.8 Sensirion AG
14.3.9 Diabeloop
14.3.10 PharmaJet
14.3.11 PenJet
14.3.12 Portal Instruments
14.3.13 Capsule Technologies
14.3.14 Propeller Health
